Review article · 2018 · Open access
Advances in developing novel therapeutic strategies for Alzheimer’s disease
Molecular Neurodegeneration, 13(1), 64 · Published 1 December 2018 · DOI 10.1186/s13024-018-0299-8
In brief
“Advances in developing novel therapeutic strategies for Alzheimer’s disease” is a 2018 review article by Jiqing Cao and 3 co-authors, published in Molecular Neurodegeneration. OpenAlex counts 289 citations as of 15 November 2026, which puts it in the top 1% of works published in 2018 by citations. It is open access under a CC BY licence: the full text is free to read at Molecular Neurodegeneration.
- Citations
- 289
- Most cited in
- 2021 (61)
- Field-weighted impact
- 4.10
- References
- 312
- Authors
- 4
Abstract
Alzheimer's Disease (AD), the most prevalent neurodegenerative disease of aging, affects one in eight older Americans. Nearly all drug treatments tested for AD today have failed to show any efficacy. There is a great need for therapies to prevent and/or slow the progression of AD. The major challenge in AD drug development is lack of clarity about the mechanisms underlying AD pathogenesis and pathophysiology. Several studies support the notion that AD is a multifactorial disease. While there is abundant evidence that amyloid plays a role in AD pathogenesis, other mechanisms have been implicated in AD such as tangle formation and spread, dysregulated protein degradation pathways, neuroinflammation, and loss of support by neurotrophic factors. Therefore, current paradigms of AD drug design have been shifted from single target approach (primarily amyloid-centric) to developing drugs targeted at multiple disease aspects, and from treating AD at later stages of disease progression to focusing on preventive strategies at early stages of disease development. Here, we summarize current strategies and new trends of AD drug development, including pre-clinical and clinical trials that target different aspects of disease (mechanism-based versus non-mechanism based, e.g. symptomatic treatments, lifestyle modifications and risk factor management).
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Cao, J., Hou, J., Ping, J., & Cai, D. (2018). Advances in developing novel therapeutic strategies for Alzheimer’s disease. Molecular Neurodegeneration, 13(1), 64. https://doi.org/10.1186/s13024-018-0299-8
MLA 9
Cao, Jiqing, et al. “Advances in developing novel therapeutic strategies for Alzheimer’s disease.” Molecular Neurodegeneration, vol. 13, no. 1, 2018, p. 64. https://doi.org/10.1186/s13024-018-0299-8.
Chicago
Cao, Jiqing, Jianwei Hou, Jing Ping, and Dongming Cai. 2018. “Advances in developing novel therapeutic strategies for Alzheimer’s disease.” Molecular Neurodegeneration 13 (1): 64. https://doi.org/10.1186/s13024-018-0299-8.
Harvard
Cao, J. et al. (2018) ‘Advances in developing novel therapeutic strategies for Alzheimer’s disease’, Molecular Neurodegeneration, 13(1), p. 64. doi:10.1186/s13024-018-0299-8.
IEEE
J. Cao, J. Hou, J. Ping, and D. Cai, “Advances in developing novel therapeutic strategies for Alzheimer’s disease,” Molecular Neurodegeneration, vol. 13, no. 1, p. 64, 2018, doi: 10.1186/s13024-018-0299-8.
BibTeX
@article{cao2018advances,
title = {{Advances in developing novel therapeutic strategies for Alzheimer’s disease}},
author = {Cao, Jiqing and Hou, Jianwei and Ping, Jing and Cai, Dongming},
journal = {Molecular Neurodegeneration},
year = {2018},
volume = {13},
number = {1},
pages = {64},
doi = {10.1186/s13024-018-0299-8},
url = {https://doi.org/10.1186/s13024-018-0299-8}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2019 | 32 | |
| 2020 | 49 | |
| 2021 | 61 | |
| 2022 | 37 | |
| 2023 | 36 | |
| 2024 | 31 | |
| 2025 | 27 | |
| 2026 | 16 |
Its field-weighted citation impact is 4.10: it has been cited 4.10 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Alzheimer's disease
- amyloid
- neurofibrillary tangles
- neuroinflammation
- protein degradation pathways
- neurotrophic factors
- prophylaxis
- early-stage disease
Work with this paper
Most-cited papers in Neuroscience
- The Rat Brain in Stereotaxic CoordinatesGeorge Paxinos, CHARLES R. R. WATSON · Elsevier eBooks · 1982 · 52,413 citations
- The assessment and analysis of handedness: The Edinburgh inventoryRichard Charles Oldfield · Neuropsychologia · 1971 · 36,725 citations
- EEGLAB: an open source toolbox for analysis of single-trial EEG dynamics including independent component analysisArnaud Delorme A, Scott Makeig · Journal of Neuroscience Methods · 2004 · 25,302 citations
- The Ecological Approach to Visual PerceptionMarc H. Bornstein, James J. Gibson · Journal of Aesthetics and Art Criticism · 1980 · 22,977 citations
- The Psychophysics ToolboxDavid H. Brainard · Spatial Vision · 1997 · 20,208 citations
Questions about this paper
How do I cite this paper in APA style?
Cao, J., Hou, J., Ping, J., & Cai, D. (2018). Advances in developing novel therapeutic strategies for Alzheimer’s disease. Molecular Neurodegeneration, 13(1), 64. https://doi.org/10.1186/s13024-018-0299-8
How many times has this paper been cited?
289 times, according to OpenAlex on 15 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access: read the free full text at Molecular Neurodegeneration.
Who wrote this paper?
Jiqing Cao, Jianwei Hou, Jing Ping, Dongming Cai.
What is the DOI of this paper?
10.1186/s13024-018-0299-8. The permanent link is https://doi.org/10.1186/s13024-018-0299-8.
Bibliographic data from OpenAlex (CC0), last checked 15 November 2026. ResearchGuru does not host this paper; the links go to the publisher or the repository that does.